3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Condylomata Acuminata
3
Neoplasms
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Keratosis, Actinic
2
Head and Neck Neoplasms
2
Breast Neoplasms
2
Wounds and Injuries
1
Virus Diseases
1
Usual Type Vulval Intraepithelial Neoplasia (uVIN)
1
Urologic Neoplasms
1
Urologic Diseases
1
Urinary Bladder Neoplasms
1
Urinary Bladder Diseases
1
Squamous Intraepithelial Lesions
1
Skin Neoplasms
1
Sexually Transmitted Diseases
1
Parapsoriasis
1
Papillomavirus Infections
1
Non-Muscle Invasive Bladder Neoplasms
1
Non-Melanoma Skin Cancers
1
Lymphoma, Follicular
1
Keratosis, Seborrheic
1
Hypogonadism
1
Hemangioma, Cavernous
1
Hemangioma
1
Fatigue
1
Exanthema
1
Eunuchism
1
Dermatitis, Contact
1
Interventions
Cisplatin
24
Carboplatin
19
Paclitaxel
18
pembrolizumab
12
Gemcitabine
12
Radiotherapy
9
Fluorouracil
9
Specimen Handling
8
Magnetic Resonance Spectroscopy
7
cemiplimab
6
Platinum
6
Nivolumab
6
Docetaxel
6
Cetuximab
6
1,2-diaminocyclohexaneplatinum II citrate
6
epothilone B
5
anlotinib
5
Sunitinib
5
Pemetrexed
5
Oxaliplatin
5
Everolimus
5
Drug Therapy
5
Cyclophosphamide
5
Capecitabine
5
Bevacizumab
5
durvalumab
4
Radiotherapy, Intensity-Modulated
4
Radiation
4
Erlotinib Hydrochloride
4
Celecoxib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Carcinoma
×
Gels
×
Clear all
NCT03546166
2023-07-21
PICABAS
Centre Hospitalier Universitaire de Nice
Phase 2
Completed
24 enrolled